← Open Payments lookup

SUE ROH: Open Payments

NPI 1619360310 · LEANDER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,588 in 129 payments from 15 companies in 2025. Trend: 2023 $2,024 · 2024 $1,858 · 2025 $2,588

Food & beverage: $2,469Education: $119
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.9$384
Otsuka America Pharmaceutical, Inc.20$329
ABBVIE INC.21$298
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$285
Alkermes, Inc.13$251
E.R. Squibb & Sons, L.L.C.10$236
Supernus Pharmaceuticals, Inc.16$199
Vanda Pharmaceuticals Inc.9$155
Axsome Therapeutics, Inc.6$137
Neurocrine BioSciences, Inc.4$133

Products named: REXULTI, VRAYLAR, CAPLYTA, COBENFY, UZEDY, Qelbree, ARISTADA, FANAPT.

Industry payments across TX — which companies pay providers there.